Inicio \ Investigación \ Publicaciones científicas \


Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target

Artículo de investigación publicado en International Journal of Molecualr Sciences

18 de marzo de 2023

A collection of repurposing drugs (Prestwick Chemical Library) containing 1200 compounds was screened to investigate the drugs` antimicrobial effects against planktonic cultures of the respiratory pathogen Streptococcus pneumoniae. After four discrimination rounds, a set of seven compounds was finally selected, namely (i) clofilium tosylate; (ii) vanoxerine; (iii) mitoxantrone dihydrochloride; (iv) amiodarone hydrochloride; (v) tamoxifen citrate; (vi) terfenadine; and (vii) clomiphene citrate (Z, E). These molecules arrested pneumococcal growth in a liquid medium and induced a decrease in bacterial viability between 90.0% and 99.9% at 25 µM concentration, with minimal inhibitory concentrations (MICs) also in the micromolar range. Moreover, all compounds but mitoxantrone caused a remarkable increase in the permeability of the bacterial membrane and share a common, minimal chemical structure consisting of an aliphatic amine linked to a phenyl moiety via a short carbon/oxygen linker. These results open new possibilities to tackle pneumococcal disease through drug repositioning and provide clues for the design of novel membrane-targeted antimicrobials with a related chemical structure




Ortiz-Miravalles L., Sanchez-Angulo M., Sanz JM. y Maestro B.




Ver artículo
Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target

Ver en NLM PubMed
Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target



Participantes:

Consejo Superior de Investigaciones CientíficasProtein Engineering against Antimicrobial Resistance Group. Centro de Investigaciones Biológicas Margarita Salas. Consejo Superior de Investigaciones Científicas (CSIC).

Universidad ComplutenseDepartamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM).

Universidad ComplutenseCentro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).

Universidad Miguel HernándezUniversidad Miguel Hernández (UMH).

Instituto de Salud Carlos IIICentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES). Instituto de Salud Carlos III (ISCIII).

Universidad ComplutenseDepartamento de Bioquímica y Biología Molecular. Facultad de Ciencias Biológicas. Universidad Complutense (UCM).







International Journal of Molecualr Sciences
FACTOR YEAR Q
5.600 2022

PMID: 36982905

ISSN: 1422-0067



TÍTULO: Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target


REVISTA: Int J Mol Sci


NUMERACIÓN: 24(6):5831


AÑO: 2023


EDITORIAL: MDPI


AUTORES: Ortiz-Miravalles L., Sanchez-Angulo M., Sanz JM. and Maestro B.


DOI: https://doi.org/10.3390/ijms24065831


CITA ESTA PUBLICACIÓN:

Ortiz-Miravalles L., Sanchez-Angulo M., Sanz JM. y Maestro B. Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target. International Journal of Molecualr Sciences. 24(6):5831. 2023. (A). ISSN: 1422-0067. DOI: 10.3390/ijms24065831